CEP85

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, CEP85 mutation is significantly associated with the RNA expression of many other genes, with 5 significant associations in total. LUNG_NSCLC_LUAD shows the largest number of these associations.

The most reproducible CEP85-associated genes across cancer lineages are SLC36A3, PRAMEF9, and H2BC1. Each is linked with CEP85 in more than 1 cancer types. Because this analysis shows association rather than direction, both CEP85-to-partner and partner-to-CEP85 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, SLC36A3 grouped by CEP85-low versus CEP85-high in LUNG_NSCLC_LUAD.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CEP85→partner) and Y-score (partner→CEP85) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUNG_NSCLC_LUADSLC36A3 →+0.018+3.866.002.00632
URINARY_TRACTPRAMEF9 →+0.013+5.087<.001.00431
LUNG_NSCLC_LUADH2BC1 →+0.436+3.544<.001.00931
LUNG_NSCLC_LUADOR5T2 →+0.007+4.078<.001.00931
CNSOR4D2 →+0.015+5.357<.001.00131
Each partner links to its Q-omics profile. Showing the 5 strongest of 5 associations by consensus.

SLC36A3 by CEP85 expression — LUNG_NSCLC_LUAD

Box plot of SLC36A3 in CEP85-low vs CEP85-high samples in LUNG_NSCLC_LUAD.

Explore this box plot interactively →

Exploration